About BioVenture
BioVenture is a company based in Suzhou (China) founded in 2013. It operates as a Professional Services and HealthTech. BioVenture offers products and services including Early-Stage Health Investments and Growth-Stage Health Investments.
- Headquarter Suzhou, China
-
Sectors
Financial Services
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioVenture
BioVenture offers a comprehensive portfolio of products and services, including Early-Stage Health Investments and Growth-Stage Health Investments.
Early-stage investments in healthcare are managed and supported.
Growth-stage healthcare investments are facilitated with strategic guidance.
Funding Insights of BioVenture
Detailed funding history for BioVenture
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioVenture
Investment portfolio details for BioVenture
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioVenture
Detailed financials for BioVenture
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioventure Comparisons
Peer comparison for BioVenture
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioVenture
Detailed competitors of BioVenture
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioventure
Complete news archive for BioVenture
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioVenture
BioVenture was founded in 2013.
BioVenture is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
BioVenture, based in Suzhou, China, is engaged in venture capital investments targeting early and growth-stage companies in the healthcare sector. The firm operates within the bioBAY ecosystem, focusing on areas such as new drug development, medical devices, in-vitro diagnostics, precision medicine, and medical services. Over 200 companies have been invested in, with 19 achieving listings on major stock exchanges. Supported by a seasoned team of investment professionals and scientific advisors, BioVenture leverages extensive industry resources and networks to guide portfolio companies. The firm is recognized as a leading healthcare investment entity in China.
BioVenture offers Early-Stage Health Investments and Growth-Stage Health Investments.